PCLO.V - PharmaCielo Ltd.
| Previous Close | 3.2700 |
| Open | 3.5000 |
| Bid | 3.4600 x 0 |
| Ask | 3.4800 x 0 |
| Day's Range | 3.3500 - 3.5500 |
| 52 Week Range | 2.5100 - 11.0900 |
| Volume | 108,022 |
| Avg. Volume | 124,762 |
| Market Cap | 339.265M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3410 |
| Earnings Date | Feb. 20, 2020 - Mar. 01, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.71 |
CNW GroupPharmaCielo Announces 30,000 Kg Cannabis Extract Agreement for German Market
TORONTO, Jan. 27, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO; OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., announced that it has entered into a three-year agreement (the "Agreement") with XPhyto Therapeutics Corp. ("XPhyto") (CSE:XPHY; FSE:4XT), whereby PharmaCielo will supply medicinal-quality cannabis extract oils and isolates, including those containing THC, to XPhyto for analysis, further processing, product development and manufacturing at its European Union Good Manufacturing Practice-certified ("EU GMP") facility in Biberach in the state of Baden-Württemberg, and thereafter for sale into the German market.
- Newsfile
XPhyto Therapeutics Announces Strategic Supply, Import and Distribution Agreement for the German Cannabis Market
Vancouver, British Columbia--(Newsfile Corp. - January 27, 2020) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) ("XPhyto" or the "Company") is pleased to announce that the Company has signed a three year definitive supply, import and distribution agreement (the "Agreement") with PharmaCielo Ltd. ("PharmaCielo"), one of the largest, highest quality, and lowest cost cannabis cultivators in the world.PharmaCielo (TSXV: PCLO) (OTCQX: PCLOF) is a global company, headquartered in Canada, with a focus on ethical ...
CNW GroupPharmaCielo Signs Pan-European Distribution Agreement for CBD Isolate and Broad-Spectrum CBD Oil
TORONTO and RIONEGRO, Colombia , Jan. 24, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., announces it has signed a three-year pan-European distribution agreement (the "Agreement"), in which the Company's high-grade CBD isolate and broad-spectrum CBD oil will be sold to wholesalers and medicinal CPG product manufacturers through GMP certified lab owner, CBD Export Global.
- Baystreet
Stocks in play: PharmaCielo Ltd.
Has been included in the newly created S&P;/TSX Cannabis Index (XCAN). The XCAN is composed of a select ...
CNW GroupPharmaCielo Added to XCAN - the Newly Created S&P/TSX Cannabis Index
TORONTO, Jan. 22, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., is pleased to announce that it has been included in the newly created S&P/TSX Cannabis Index (XCAN). The XCAN is composed of a select group of issuers traded on the TSX and TSX Venture Exchanges, each of which has been vetted by the TSX Market Intelligence Group. PharmaCielo Ltd. (TSXV: PCLO, OTCQX: PCLOF) is a global company, headquartered in Canada, with a focus on ethical and sustainable processing and supplying of all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors.
CNW GroupPharmaCielo Becomes First Cultivator Awarded Good Agricultural Practices (GAP) Global Certification for Colombian Medicinal-Cannabis Operations
TORONTO and RIONEGRO, Colombia , Jan. 20, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., is pleased to announce that the Company has received the global Good Agricultural Practices (GAP) certification for its propagation, flowering and medical cannabis production operations in Colombia .
- Market Exclusive
PharmaCielo Approved to Export CBD Isolate from Colombia to U.S.
PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's cultivator and producer of medicinal-grade cannabis extracts PharmaCielo Colombia Holdings S.A.S., announced that it has received approval from the TSX Venture Exchange (TSXV) for the export of medicinal grade CBD isolate from Colombia to a distributor in the U.S. "We believe we are the […]The post PharmaCielo Approved to Export CBD Isolate from Colombia to U.S. appeared first on Market Exclusive.
- Simply Wall St.
Those Who Purchased PharmaCielo (CVE:PCLO) Shares A Year Ago Have A 39% Loss To Show For It
PharmaCielo Ltd. (CVE:PCLO) shareholders should be happy to see the share price up 20% in the last month. But that...
CNW Group/C O R R E C T I O N from Source -- PharmaCielo Ltd./
In the news release, PharmaCielo Receives Acceptance from TSX Venture Exchange of Supply Agreement for Export of 2018 Farm Bill Compliant CBD Isolate to United States, issued 17-Jan-2020 by PharmaCielo Ltd. over CNW, we are advised by the company that "hemp derived" should be removed from the first sentence of the fourth paragraph. TORONTO, Jan. 17, 2020 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., announced that further to its September 25, 2019 press release relating to a supply agreement (the "Supply Agreement") it has received TSX Venture Exchange ( "TSXV") approval of the export from Colombia of medicinal grade CBD isolate that is compliant with the 2018 Farm Bill to a distributor in the United States who had placed an order for up to US$3 million under the Supply Agreement.
CNW GroupPharmaCielo Awarded Game-Changer Award by MJDaily
TORONTO and RIONEGRO, Colombia , Dec. 14, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., has been recognized with the prestigious MJ Biz Daily Game-Changer Award for the Latin America Region. It means that whatever we do, every step of progress achieved, is a first for the industry, with the rule book written as we go.
CNW GroupPharmaCielo Announces Receipt of CAD$3.9 Million Secured Loan Repayment
TORONTO, Dec. 5, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO, OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced that Creso Pharma Limited ("Creso") (ASX:CPH.AX - News) has repaid in full, all principal and interest owing to the Company in the amount of approximately CAD$3.9 million under the secured bridge loan by PharmaCielo to Creso that was made pursuant to an amendment to Creso's existing loan deed, originally entered into with an arm's length party to Creso on April 26, 2019 (the "Secured Bridge Loan").
CNW GroupPharmaCielo Graduates to OTCQX® Best Market and Secures DTC Eligibility
TORONTO , Dec. 2, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO, OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., is pleased to announce that the Company has qualified to trade on the OTCQX® Best Market in the United States and secured Depository Trust Company ("DTC") eligibility. PharmaCielo's shares were previously traded on the OTC Markets' Pink® Market under the ticker "PHCEF" and have begun trading today on the top tier OTCQX® Best Market under an updated ticker symbol of "PCLOF".
CNW GroupPharmaCielo Announces Financial Results for the Three and Nine Months Ended September 30, 2019
Well capitalized with cash and short-term investments of $20.7 million as of September 30, 2019 . Nearing completion of extraction and processing center ("RTC"), which will expand the Company's extraction capacity to 265 tonnes of dried flower per year ( processed equivalent volume of 28,900 kg of cannabis oil per year). TORONTO and RIONEGRO, Colombia , Nov. 25, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO, OTC: PHCEF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., today announced financial results for the three- and nine-month periods ended September 30, 2019 .
CNW GroupPharmaCielo Announces RSU Grant
TORONTO , Nov. 8, 2019 /CNW/ - PharmaCielo Ltd. (" PharmaCielo " or the " Company ") ( TSXV:PCLO, OTC:PHCEF ) today announced that on November 5, 2019 (the " Grant Date ") ...
- CNW Group
IIROC Trading Resumption - PCLO
VANCOUVER , Nov. 6, 2019 /CNW/ - Trading resumes in: Company: Pharmacielo Ltd. TSX-Venture Symbol: PCLO Resumption (ET): 09:30 AM IIROC can make a decision to impose a temporary suspension (halt) of trading ...
